Association of RASis and HMG-CoA reductase inhibitors with clinical manifestations in coronavirus disease 2019 patients: Results from the Khorshid Coronavirus Disease Cohort Study

BACKGROUND: Angiotensin II receptor blockers (ARBs) and angiotensin-converting enzyme inhibitors (ACEinhs) may deteriorate or improve the clinical manifestations in severe acute respiratory syndrome coronavirus 2 infection. A comparative, cross-sectional study was conducted to evaluate the associati...

Descripción completa

Detalles Bibliográficos
Autores principales: Iraj, Bijan, Moravejolahkami, Amir Reza, Sami, Ramin, Riahinezhad, Maryam, Tasdighi, Zahra, Toghyani, Arash, Hosseini, Nastaran Sadat, Niri, Fatemeh Dehghan, Askari, Gholamreza
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10098137/
https://www.ncbi.nlm.nih.gov/pubmed/37064792
http://dx.doi.org/10.4103/jrms.jrms_373_22

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10098137/
https://www.ncbi.nlm.nih.gov/pubmed/37064792
http://dx.doi.org/10.4103/jrms.jrms_373_22

Ejemplares similares